Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine.
about
Consequences of hypoxia-reoxygenation phenomena in patients with obstructive sleep apnea syndromeBrachial artery diameter, blood flow and flow-mediated dilation in sleep-disordered breathing.Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea.Hypoxia-induced vasodilation and effects of regional phentolamine in awake patients with sleep apnea.Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment.Cardiovascular disease risk reduction with sleep apnea treatment.The Role of Obesity in Preeclampsia.Endothelial function in obstructive sleep apnea.Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies.Implications of sleep-disordered breathing in pregnancy.Endothelial dysfunction in obstructive sleep apnea.Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approachesObstructive sleep apnoea syndrome: translating science to clinical practice.Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more.Sleep and the metabolic syndrome.Hypertension research in sleep apnea.Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome.Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk.Mechanisms of endothelial dysfunction in obstructive sleep apnea.Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.Cardiovascular complications of sleep apnea: role of oxidative stressArginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome.Non-dipping pattern of hypertension and obstructive sleep apnea syndrome.Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea.Importance and management of chronic sleep apnoea in cardiology.The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases.The Endothelium as a Target in Pediatric OSA.Cerebrovascular reactivity and neurovascular coupling in patients with obstructive sleep apnea.Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome.Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives.Effect of oral appliance on endothelial function in sleep apnea.The correlation of serum levels of leptin, leptin receptor and NO x (NO 2 (-) and NO 3 (-)) in patients with obstructive sleep apnea syndrome.Effect of uvulopalatopharyngoplasty on leptin and endothelial function in sleep apnea.Chronic intermittent hypoxia accelerates coronary microcirculatory dysfunction in insulin-resistant Goto-Kakizaki rats.Cardiovascular consequences of sleep apnea.Obstructive sleep apnea exacerbates endothelial dysfunction in people with metabolic syndrome.Effect of revised UPPP surgery on ambulatory BP in sleep apnea patients with hypertension and oropharyngeal obstruction.
P2860
Q24631000-9421B0BA-5668-44EF-9C61-1116E75DD0F2Q33508971-032E639A-71BA-46AE-9447-C34A001E5DB8Q33748662-C04A53E6-69CA-4F4B-8D56-349288E9CE94Q33841102-92BD32C1-A105-4659-9DAC-B2E3318E2ACBQ34348192-100DD366-45C9-4F25-B680-F0B1DDB2EF88Q34522833-283BD2E9-EDDD-4568-9417-CD312A1A88AEQ34853745-A76B2169-6D46-4C96-B66F-07445ECB5088Q35086889-F6D88E4E-EBDB-4539-A7BE-EFC5E7574EF2Q35625951-6AED68BA-A16A-468B-82B6-CC9C3C0F7DBCQ35763744-627DEE87-5726-47E3-87B4-6E2643260D51Q35880081-6739E1E0-44C1-4401-8C56-0BF38E84C628Q35995356-62FA012F-F66E-40DF-9E10-106E815BABA4Q36273357-4AC50C33-AD5D-43A8-8F57-E6F29E24BEACQ36396309-65A90DAC-8661-44EF-9D48-572E5DE82481Q36426073-1E4EA184-3BE0-409B-8BAC-7A8344213CCCQ36482623-EB606ADB-9192-4BFB-A4C4-9C690A32065CQ36645393-7AE85D89-3E57-46E3-AE8C-A47EE8D17331Q36684804-239B498E-2A50-45F3-84FB-F0AAAD6C6E90Q36883231-89D7CB93-EF3B-4005-9C35-DC7B07D96475Q36891461-1482F4E4-068C-4CD2-A364-DD9FDA7EB82AQ37145667-9A267895-7CAF-47B7-88B1-56D6728CF995Q37275639-A52E637D-6312-4F9B-87ED-A408E1E6D88EQ37464853-C39D6ED4-C67C-420F-AD54-74AB0C3FCCCFQ37661625-A982A486-E43D-421F-AAE4-CAFE8B932524Q37676877-36B12A0D-A1DB-4183-A60E-A7DB6BD1B97AQ37785487-68CCD115-2B34-49BD-BD82-908DF71DB11AQ37863567-1A8A9C29-7D52-445C-B60D-DD50DCF29CD7Q37994656-BF5DD589-4E89-442B-9516-E83B4E040F98Q38203518-B45DFA2A-F8DC-44A6-8A35-8783F4E2D27CQ39602294-B5856BEF-3350-454D-A164-D054113D7E56Q40038213-B0B3CBA3-13CA-48FE-B961-C0DEB706954AQ45894281-EC2E100E-2669-4251-A340-866CC28A2DB6Q46441684-6204AF20-F697-485E-8088-3001CE47BC93Q48115616-C279A887-FD6E-43F4-A86A-EE50769C4E38Q48121093-CCAF4812-F359-4E01-A10D-095840684080Q48123483-CD1E127B-21EE-4C60-93A4-7C4796F7FFBBQ48215443-2481BEC6-C8FC-4B6E-B5B0-83318C63070BQ48275734-20E54889-4E2D-40E3-9393-05E16C4AF1E6Q48287863-D5370E50-D258-4211-8147-F822BA6DD540Q48371735-7779A4AB-F177-4400-AC99-FC0527989E92
P2860
Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Amelioration of vascular endot ...... etric NG, NG-dimethylarginine.
@en
Amelioration of vascular endot ...... etric NG, NG-dimethylarginine.
@nl
type
label
Amelioration of vascular endot ...... etric NG, NG-dimethylarginine.
@en
Amelioration of vascular endot ...... etric NG, NG-dimethylarginine.
@nl
prefLabel
Amelioration of vascular endot ...... etric NG, NG-dimethylarginine.
@en
Amelioration of vascular endot ...... etric NG, NG-dimethylarginine.
@nl
P2093
P356
P1433
P1476
Amelioration of vascular endot ...... etric NG, NG-dimethylarginine.
@en
P2093
Eijiro Ohga
Katsuya Iijima
Kazuhiro Imai
Koichi Kozaki
Masao Yoshizumi
Masato Eto
Masayoshi Hashimoto
Taro Kojima
Tomofumi Santa
Yasuyoshi Ouchi
P304
P356
10.1253/CIRCJ.69.221
P577
2005-02-01T00:00:00Z